Crohn Disease
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.
|
26192919 |
2015 |
Crohn Disease
|
|
0.800 |
GeneticVariation
|
GWASDB |
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
|
23128233 |
2012 |
Crohn Disease
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
|
23128233 |
2012 |
HIV-1, RESISTANCE TO
|
|
0.800 |
GeneticVariation
|
GWASCAT |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
AIDS, PROGRESSION TO
|
|
0.800 |
GeneticVariation
|
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
|
0.800 |
GeneticVariation
|
GWASCAT |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
|
0.800 |
GeneticVariation
|
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
|
0.800 |
GeneticVariation
|
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
HIV-1, RESISTANCE TO
|
|
0.800 |
GeneticVariation
|
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
AIDS, PROGRESSION TO
|
|
0.800 |
GeneticVariation
|
GWASCAT |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
|
0.800 |
GeneticVariation
|
GWASCAT |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
|
0.800 |
GeneticVariation
|
GWASDB |
Common genetic variation and the control of HIV-1 in humans.
|
20041166 |
2009 |
AIDS, PROGRESSION TO
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Common genetic variation and the control of HIV-1 in humans.
|
20041166 |
2009 |
AIDS, PROGRESSION TO
|
|
0.800 |
GeneticVariation
|
GWASDB |
Common genetic variation and the control of HIV-1 in humans.
|
20041166 |
2009 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Common genetic variation and the control of HIV-1 in humans.
|
20041166 |
2009 |
HIV-1, RESISTANCE TO
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Common genetic variation and the control of HIV-1 in humans.
|
20041166 |
2009 |
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Common genetic variation and the control of HIV-1 in humans.
|
20041166 |
2009 |
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
|
0.800 |
GeneticVariation
|
GWASDB |
Common genetic variation and the control of HIV-1 in humans.
|
20041166 |
2009 |
HIV-1, RESISTANCE TO
|
|
0.800 |
GeneticVariation
|
GWASDB |
Common genetic variation and the control of HIV-1 in humans.
|
20041166 |
2009 |
IGA Glomerulonephritis
|
|
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy.
|
22197929 |
2011 |
HIV-1 VIREMIA, SUSCEPTIBILITY TO
|
|
0.700 |
SusceptibilityMutation
|
CLINVAR |
|
|
|
Hepatitis C
|
|
0.010 |
GeneticVariation
|
BEFREE |
In this study, we examined the impact of the rs9264942 single-nucleotide polymorphism, previously shown to be associated with human immunodeficiency virus infection status and HLA-C expression, on the hepatitis C virus status in 359 people who inject drugs (PWID).
|
30102364 |
2018 |
HIV-1 infection
|
|
0.010 |
GeneticVariation
|
BEFREE |
We evaluated the distribution of HLA-C (rs10484554, rs9264942) and ZNRD1 (rs8321) and ZNRD1-AS1 (rs3869068), single nucleotide polymorphisms (SNPs) in 266 HIV-1-infected and 223 unexposed-uninfected individuals from Northeast Brazil and their relation to HIV-1 infection, CD4 T cells count and viral load pre-treatment.
|
28494720 |
2017 |
Psoriasis vulgaris
|
|
0.010 |
GeneticVariation
|
BEFREE |
Whether rs9264942 SNP is associated with PsV was investigated here. rs9264942T>C was genotyped in 292 PsV patients, and 254 controls using TaqMan Genotyping Assay.
|
24759677 |
2014 |
Autoimmune Diseases
|
|
0.010 |
GeneticVariation
|
BEFREE |
HLA class I molecules play a role both in viral infection control and in autoimmune diseases development. rs9264942T>C polymorphism in HLA-C gene was found to impact on HLA-C surface expression level and to be associated with HIV-1 control.
|
24759677 |
2014 |